Previous close | 168.00 |
Open | 186.00 |
Bid | 202.70 x 20000 |
Ask | 204.20 x 20000 |
Day's range | 186.00 - 190.05 |
52-week range | 126.40 - 218.20 |
Volume | |
Avg. volume | 25 |
Market cap | 29.899B |
Beta (5Y monthly) | 0.67 |
PE ratio (TTM) | 31.36 |
EPS (TTM) | 6.06 |
Earnings date | 25 Apr 2024 |
Forward dividend & yield | 1.79 (0.94%) |
Ex-dividend date | 08 May 2024 |
1y target est | 261.67 |
Insightful Analysis of ResMed Inc's Financial Health and Strategic Position
ResMed stock jumped Friday after crushing sales estimates and wiping out worries that weight-loss drugs would squeeze sleep apnea device sales.
Integer Holdings' (ITGR) first-quarter results reflect robust Medical Sales, along with strength in all the product lines.